Evidence of Dementia Treatment using Vitamin D: A Systematic Review

  • Micah Nyabiba Asamba Kenyatta University
##plugins.pubIds.doi.readerDisplayName##: https://doi.org/10.37284/eajhs.8.1.2642
##share.article##:

Résumé

Dementia is a progressive cognitive decline that poses significant public health concerns, particularly among the ageing population. Recent evidence highlights vitamin D's neuroprotective roles, including its involvement in neurotransmission, antioxidative processes, and neuronal preservation. This systematic review examined ten studies from 2011 to 2020, including randomized controlled trials (RCTs), cross-sectional studies, and longitudinal studies, to evaluate vitamin D's efficacy in treating dementia. Findings demonstrated that vitamin D supplementation improves cognitive function, particularly in patients with mild cognitive impairment and dementia. High-dose supplementation exhibited enhanced effects on visuospatial memory and executive functions compared to low-dose supplementation in some studies. However, results varied due to differences in study populations, methodologies, and follow-up durations. Despite its limitations, including small sample sizes and short study periods, this review underscores the potential of vitamin D as a complementary intervention in dementia care. Further research is needed to establish optimal dosing and explore its long-term effects on cognitive health

##plugins.generic.usageStats.downloads##

##plugins.generic.usageStats.noStats##

Références

Annweiler, C., Allali, G., Allain, P., Bridenbaugh, S., Schott, A.-M., Kressig, R. W., & Beauchet, O. (2009). Vitamin D and cognitive performance in adults: a systematic review. European Journal of Neurology, 16(10), 1083–1089. https://doi.org/10.1111/j.1468-1331.2009.02755.x

Annweiler, C., Brugg, B., Peyrin, J.-M., Bartha, R., & Beauchet, O. (2014). Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiology of Aging, 35(2), 331– 335. https://doi.org/10.1016/j.neurobiolaging.2013.07.029

Annweiler, C., Fantino, B., Gautier, J., Beaudenon, M., Thiery, S., & Beauchet, O. (2012a). Cognitive Effects of Vitamin D Supplementation in Older Outpatients Visiting a Memory Clinic: A Pre-Post Study. Journal of the American Geriatrics Society, 60(4), 793– 795. https://doi.org/10.1111/j.1532-5415.2011.03877.x

Annweiler, C., Herrmann, F. R., Fantino, B., Brugg, B., & Beauchet, O. (2012b). Effectiveness of the Combination of Memantine plus Vitamin D on Cognition in Patients with Alzheimer Disease. Cognitive and Behavioral Neurology, 25(3), 121–127. https://doi.org/10.1097/wnn.0b013e31826df647

Balion, C., Griffith, L. E., Strifler, L., Henderson, M., Patterson, C., Heckman, G., Llewellyn, D. J., & Raina, P. (2012). Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology, 79(13), 1397–1405. https://doi.org/10.1212/WNL.0b013e31826c197f

Berg-Weger, M., & Stewart, D. B. (2017). Non-Pharmacologic Interventions for Persons with Dementia. Missouri Medicine, 114(2), 116–119. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140014/

Bhatti, G. K., Reddy, A. P., Reddy, P. H., & Bhatti, J. S. (2020). Lifestyle Modifications and Nutritional Interventions in Aging-Associated Cognitive Decline and Alzheimer’s Disease. Frontiers in Aging Neuroscience, 11. https://doi.org/10.3389/fnagi.2019.00369

Buell, J. S., & Dawson-Hughes, B. (2008). Vitamin D and neurocognitive dysfunction: Preventing “D”ecline? Molecular Aspects of Medicine, 29(6), 415–422. https://doi.org/10.1016/j.mam.2008.05.001

Byrn, M. A., Adams, W., Penckofer, S., & Emanuele, M. A. (2019). Vitamin D Supplementation and Cognition in People with Type 2 Diabetes: A Randomized Control Trial. Journal of Diabetes Research, 2019(1), 1–13. https://doi.org/10.1155/2019/5696391

Chai, B., Gao, F., Wu, R., Dong, T., Gu, C., Lin, Q., & Zhang, Y. (2019). Vitamin D deficiency as a risk factor for dementia and Alzheimer’s disease: an updated meta-analysis. BMC Neurology, 19(1). https://doi.org/10.1186/s12883-019-1500-6

D’Onofrio, G., Sancarlo, D., Seripa, D., Ricciardi, F., Giuliani, F., Panza, F., & Greco, A. (2016). Non-Pharmacological Approaches in the Treatment of Dementia. Update on Dementia. https://doi.org/10.5772/64232

Dean, A. J., Bellgrove, M. A., Hall, T., Phan, W. M. J., Eyles, D. W., Kvaskoff, D., & McGrath, J. J. (2011). Effects of Vitamin D Supplementation on Cognitive and Emotional Functioning in Young Adults – A Randomised Controlled Trial. PLoS ONE, 6(11), e25966. https://doi.org/10.1371/journal.pone.0025966

Dickens, A. P., Lang, I. A., Langa, K. M., Kos, K., & Llewellyn, D. J. (2011). Vitamin D, Cognitive Dysfunction and Dementia in Older Adults. CNS Drugs, 25(8), 629–639. https://doi.org/10.2165/11593080-000000000-00000

Dursun, E., Gezen-Ak, D., & Yilmazer, S. (2011). A Novel Perspective for Alzheimer’s Disease: Vitamin D Receptor Suppression by Amyloid-β and Preventing the Amyloid-β Induced Alterations by Vitamin D in Cortical Neurons. Journal of Alzheimer’s Disease, 23(2), 207–219. https://doi.org/10.3233/jad-2010-101377

Etgen, T., Sander, D., Bickel, H., Sander, K., & Förstl, H. (2012). Vitamin D Deficiency, Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis. Dementia and Geriatric Cognitive Disorders, 33(5), 297– 305. https://doi.org/10.1159/000339702

Gangwar, A. K., Rawat, A., Tiwari, S., Tiwari, S. C., Narayan, J., & Tiwari, S. (2015). Role of Vitamin-D in the prevention and treatment of Alzheimer’s disease. Indian Journal of Physiology and Pharmacology, 59(1), 94–99. https://pubmed.ncbi.nlm.nih.gov/26571990/

Hooshmand, B., Lökk, J., Solomon, A., Mangialasche, F., Miralbell, J., Spulber, G., Annerbo, S., Andreasen, N., Winblad, B., Cedazo-Minguez, A., Wahlund, L.-O., & Kivipelto, M. (2014). Vitamin D in Relation to Cognitive Impairment, Cerebrospinal Fluid Biomarkers, and Brain Volumes. The Journals of Gerontology: Series A, 69(9), 1132–1138. https://doi.org/10.1093/gerona/glu022

Iacopetta, K., Collins-Praino, L. E., Buisman-Pijlman, F. T. A., Liu, J., Hutchinson, A. D., & Hutchinson, M. R. (2018). Are the protective benefits of vitamin D in neurodegenerative disease dependent on route of administration? A systematic review. Nutritional Neuroscience, 23(4), 251–280. https://doi.org/10.1080/1028415x.2018.1493807

Lee, G. E., Kim, J. Y., Jung, J. H., Kang, H. won, & Jung, I. C. (2019). Non-pharmacological interventions for patients with dementia. Medicine, 98(38), e17279. https://doi.org/10.1097/md.0000000000017279

Masoumi, A., Goldenson, B., Ghirmai, S., Avagyan, H., Zaghi, J., Abel, K., Zheng, X., Espinosa-Jeffrey, A., Mahanian, M., Liu, P. T., Hewison, M., Mizwicki, M., Cashman, J., & Fiala, M. (2009). 1α, 25-dihydroxyvitamin D3 Interacts with Curcuminoids to Stimulate Amyloid-β Clearance by Macrophages of Alzheimer’s Disease Patients. Journal of Alzheimer’s Disease, 17(3), 703–717. https://doi.org/10.3233/jad-2009-1080

Miller, J. W., Harvey, D. J., Beckett, L. A., Green, R., Farias, S. T., Reed, B. R., Olichney, J. M., Mungas, D. M., & DeCarli, C. (2015). Vitamin D Status and Rates of Cognitive Decline in a Multiethnic Cohort of Older Adults. JAMA Neurology, 72(11), 1295. https://doi.org/10.1001/jamaneurol.2015.2115

Pettersen, J. A. (2017). Does high dose vitamin D supplementation enhance cognition?: A randomized trial in healthy adults. Experimental Gerontology, 90, 90–97. https://doi.org/10.1016/j.exger.2017.01.019

Stein, M. S., Scherer, S. C., Ladd, K. S., & Harrison, L. C. (2011). A Randomized Controlled Trial of High-Dose Vitamin D2 Followed by Intranasal Insulin in Alzheimr’s Disease. Journal of Alzheimer’s Disease, 26(3), 477–484. https://doi.org/10.3233/jad-2011-110149

van der Schaft, J., Koek, H. L., Dijkstra, E., Verhaar, H. J. J., van der Schouw, Y. T., & Emmelot-Vonk, M. H. (2013). The association between vitamin D and cognition: a systematic review. Ageing Research Reviews, 12(4), 1013–1023. https://doi.org/10.1016/j.arr.2013.05.004

Yang, T., Wang, H., Xiong, Y., Chen, C., Duan, K., Jia, J., & Ma, F. (2020). Vitamin D Supplementation Improves Cognitive Function Through Reducing Oxidative Stress Regulated by Telomere Length in Older Adults with Mild Cognitive Impairment: A 12-Month Randomized Controlled Trial. Journal of Alzheimer’s Disease, 78(4), 1509–1518. https://doi.org/10.3233/jad-200926

Publiée
27 janvier, 2025